THE GLOBAL PROTEOMICS MARKET WAS VALUED AT USD 25.13 BILLION IN 2021 AND IS EXPECTED TO REACH USD 50.69 BILLION BY 2027, GROWING AT A CAGR OF 12.41%.

Global Proteomics Market Size, Share, & Trends Analysis Report by

  • Product: Consumables & Reagents, Instruments & Software, and Services
  • Application: DDD & TR, Clinical, Applications, and Forensic & Applied Proteomics
  • End-User: Pharma & Biotech, Academic & Research Institutes, Hospitals, and Diagnostic & Forensic
  • Geography: North America, Europe, APAC, Latin America, and Middle East & Africa

Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022–2027

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

299 Pages

icon-table

80 Tables

icon-chart

149 Charts

icon-region

5 Regions

icon-country

18 Countries

icon-company

36 Companies

icon-market

4 Market Segment

GLOBAL PROTEOMICS MARKET REPORT SCOPE

Report Attribute Details
Market Size (2027) USD 50.69 Billion
Market Size (2021) USD 25.13 billion
CAGR (2022-2027) 12.41%
Base Year 2021
Forecast Year 2022-2027
Market Segments Product, Application, End-User, and Geography
Geographic Analysis North America, Europe, APAC, Latin America, and Middle East & Africa
Countries Covered US, Canada, Germany, France, UK, Italy, Spain, Japan, China, South Korea, Australia, India, Brazil, Mexico, Argentina, Turkey, South Africa, and Saudi Arabia

MARKET OVERVIEW

The global proteomics market was valued at USD 25.13 billion in 2021 and is expected to reach USD 50.69 billion by 2027, growing at a CAGR of 12.41%. Increasing awareness among the people regarding applications of proteomics in drug discovery and development, biomarker discovery, and clinical diagnostics for disease diagnosis and treatment is propelling the market's growth. Many private and public research organizations focus on developing proteomics based on spectrometry.

Proteomics is the extensive study of proteins, a rapidly growing field in disease diagnosis. It identifies disease-associated proteins and studies their function, structure, and expression. Proteomics researchers primarily rely on sophisticated technology to deliver actionable insights to advance the field because of the number of complexities in proteomics. Proteomics is a key tool in medical research because it allows studying large-scale proteins from various biological samples to discover new protein biomarkers for different disease conditions.

Proteomics allows for the discovery of new protein biomarkers for diagnostic applications and the investigation of novel molecular targets for medication development and discovery. Protein expression profiling, targeted protein quantification, protein-protein interaction analysis, and post-translational modifications are all possible using proteomics. Proteomics has demonstrated its utility in biomarker identification, medication development, and precision medicine.

 

Global Proteomics Market Size

IMPACT OF COVID-19 ON PROTEOMICS MARKET

The impact of COVID-19 is also seen in the proteomics market's growth. There has been increased research on diagnostics, biomarker discovery, and drug discovery and development against COVID-19. It has accelerated the involvement of proteomics. Several large and small companies have constantly been coming up with immunoassay kits to detect COVID-19 rapidly. Along with companies, many public/private research organizations and research institutes also increased the research on the coronavirus involving the proteomics approach extensively.  

Proteomics plays a considerable role in drug development, and therefore, many drug manufacturers have started their proteomics divisions that fuel the growth of the global proteomics market. 

Existing technologies have several drawbacks, including a lack of specificity, especially in high-multiplex assays, a lack of sensitivity, and a lack of precision; a limited dynamic range (the ability to measure a wide range of concentrations reliably and simultaneously); a high sample consumption requirement; a lack of scalability; a low throughput; data complexity; and a high cost. This scenario is changing over time and will enhance the scope of proteomics. 

Proteomics technologies in the market include spectrometry, microarray, chromatography, and reagents used for proteomic analysis. The majority of proteomic analysis primarily relies on an expensive and complex analysis of proteome complexity at the level of amino acid variants, which have the potential to generate important biological insights. 

NANOPROTEOMICS: LUCRATIVE OPPORTUNITY IN THE PROTEOMICS MARKET 

Nanoproteomics offers real-time multiplexed analysis, rapid and miniatured assay, low sample consumption, and high sensitivity, thereby finding many applications for proteomic investigations.

The growing prominence of nanoproteomics offers significant growth opportunities for players in the market. Nanoproteomics is still in its early stage of enabling broad biomedical applications. In the upcoming years, continuous technological advancement in this field is anticipated. The growing prominence of nanoproteomics offers significant growth opportunities for players in this market. 

BGI, a China-based company, has extensive experience in nanoproteomics. The company offers a nanoproteomics service, serving in more than 66 countries. Seer company's photograph product suite, an integrated solution, consists of the company's proprietary engineered nanoparticles, consumables, automation instrument, and software that allows proteomics studies. It reduces the complexity of traditional proteomics. It has commercialized its services using the proteograph product suite with North America, Europe, and the Asia Pacific providers. 

CONSUMABLES & REAGENT: HIGHEST REVENUE CONTRIBUTOR 

The consumables and reagents segment has the largest market share accounting for 77.08% in 2021. For several decades, many companies have included both small and large companies, relentlessly working to bring more reagents and consumables used in all the areas of proteomics application in the initial step, which is during the sample preparation. Many vital companies offer a wide range of consumables and reagents, such as Agilent Technologies, Bio-Rad Laboratories, and Thermo Fisher Scientific. An increase in the reagent's portfolio is evitable with the increasing proteomics research worldwide. These factors make the consumables and reagents segment the highest revenue maker, with $19.37 billion in 2021.

THE INSTRUMENTS AND SOFTWARE MARKET IS TO GROW AT A CAGR OF 13% FROM 2022 TO 2027.

Most key companies offer a wide range of instruments for microarray, spectrometry, chromatography, electrophoresis, surface plasma resonance, and x-ray crystallography. With the increasing research on biomarker discovery and drug discovery and development, several pharmaceutical companies and academic & research institutes are expected to increase the implementation of instruments and software in their laboratories. Hence, the instruments & software segment is expected to increase in the forecast period with a CAGR of 13%.

END-USER INSIGHTS 

Among all the end-users, the pharmaceutical and biotechnology companies segment is growing due to the development and demand of the increasing diagnostic for drug development. The surge in the use of proteomic technology is also due to the rising adoption of precision medicine driven by biomarkers identification and discovery in response to the increasing prevalence of chronic diseases such as cancer mainly. 

Several academic and research institutes are also the second major revenue generator in the proteomics market, increasing research on developing drugs and vaccines. Hospitals are also using proteomics technologies for disease diagnosis purposes. They either have their in-house pathology laboratory or collaborate with a diagnostic laboratory, and they get the diagnosis done by sending the samples. In collaboration or partnership with proteomics companies, several hospitals are enabling the companies to develop related proteomic technologies.

Forensic laboratories are also contributing and accounting for a good market share in growing the proteomics markets by receiving massive funding and investments to conduct research in forensic science for protein identification and biomarker discovery. 

WIDE ACCEPTANCE AMONG ACADEMIC AND RESEARCH INSTITUTES

While Pharmaceutical and Biotechnology, companies are the highest revenue generator segment, with $11.76 billion in 2021. Academic & research institutes are the most significant users of proteomics technologies for various ongoing research activities in multiple dimensions: discovery, new technology innovations, better product advancements, academic training, etc. The Academic and Research institutes segment is expected to grow at the highest CAGR of 12.91%. 

GEOGRAPHY INSIGHTS

Increasing adoption of personalized medicine, increasing R&D expenditures for drug discovery, biomarker discovery, and biomarker-driven development of precision medicine are the major factors that drive the growth of the proteomics market worldwide.

Increasing awareness among the people regarding applications of proteomics in drug discovery and development, biomarker discovery, and clinical diagnostics for disease diagnosis and treatment is also propelling the market's growth. Some private and public research organizations focus on developing proteomics based on spectrometry.

In North America, Europe, and APAC region, increased funding by the government for the R&D activities boosts growth opportunities for the key players in the market to develop advanced proteomics diagnostics and instruments in the forecast period. However, in these regions, a lack of skilled professionals is limiting the growth of the proteomics market. In North America and APAC region, the introduction of nanotechnology in proteomics is trending and has shown vast opportunities for acceptance. For instance, in China, BGI Genomics is offering nano proteomics services. 

Middle East, Africa, and Latin America are showing a growing focus on the adoption of precision medicine. The governments have taken several initiatives to accelerate the growth of the proteomics market in Latin America, the Middle East, and Africa. Also, the rising popularity of personalized medicine increased research on biomarkers and drug discovery, driving the proteomics market in Latin America, the Middle East, and Africa. However, stringent regulatory norms and the high cost of proteomics instruments, lack of funds and investments, lack of awareness about proteomics, and lack of skilled professionals are restraining these regions from adopting advanced proteomics approaches.  

VENDOR ANALYSIS

Vendors are divided into both manufacturers and service providers. The proteomics market is highly dynamic and competitive, with global, regional, and local players offering a wide range of proteomics solutions. Agilent Technologies, Bio-Rad Laboratories, Thermo-Fisher Scientific, Danaher, and PerkinElmer are the significant players in providing products in proteomics, whereas BGI Group is a substantial player in offering proteomics services.

  • Expansion activities (regional business and facility expansions) are helping players strengthen the global distribution networks and thus allowing the players to explore untapped opportunities. 
  • Increasing product launches 
  • Large scale investments in the single-use bioprocessing probes and sensors market through varied conglomerates and investments firms 
  • Forging collaborations and partnerships with well-established manufacturers, academic & research institutes, hospitals, and diagnostic & forensic laboratories is cementing the players' footprints. 
  • Strategic acquisitions continue to be an essential competitive strategy for key players to expand their product offerings, access new technology, or increase market share.
  • In low and middle-income countries, the service providers are mainly in demand as these countries do lack proper healthcare infrastructure.
  • Service providers are focusing on increasing the collaborations with hospitals and several pharmaceutical companies to grow in the market. 

The need for companies that provide proteomics services has drawn the attention of many researchers from laboratories that are not equipped with advanced technologies for proteomic research. This could be due to a lack of skilled professionals or in-house infrastructure, as increased demand for proteomics research. Many companies have emerged by providing protein identification, quantification, sequencing, purification, and custom assay services.

Frequently Asked Questions

HOW BIG IS THE GLOBAL PROTEOMICS MARKET?

The global proteomics market was valued at USD 25.13 billion in 2021 and is expected to reach USD 50.69 billion by 2027.

WHAT IS THE GROWTH RATE OF THE GLOBAL PROTEOMICS MARKET?

The global proteomics market is expected to grow at a CAGR of 12.41% during 2022-2027.

WHO ARE THE KEY PLAYERS IN THE GLOBAL PROTEOMICS MARKET?

Key players include Agilent Technologies, Bio-Rad Laboratories, Danaher, Thermo Fisher Scientific, PerkinElmer, and BGI Genomics.

WHAT ARE THE GROWTH FACTORS IN THE GLOBAL PROTEOMICS MARKET?

The increasing number of research and development activities in proteomics, rising prevalence of cancer and various genetic disorders, and growing focus on the development of precision medicine are the growth factors in the global proteomics market.

WHAT ARE THE LATEST TRENDS IN THE GLOBAL PROTEOMICS MARKET?

Development in mass spectrometry-based proteomics, Increasing Prominence of Nanoproteomics, and proteomics revolutionizing diabetes management are the latest trends in the market.

Download Free Sample

The global proteomics market was valued at USD 25.13 billion in 2021 and is expected to reach USD 50.69 billion by 2027, growing at a CAGR of 12.41%.

The following factors will drive the global proteomics market growth during the forecast period:

  • Increasing Number of Research and Development Activities in Proteomics
  • Rising Prevalence of Cancer and Various Genetic Disorders
  • Growing Focus on Development of Precision Medicine

The study considers a detailed scenario of the present global proteomics market and its dynamics for 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the industry.

Base Year: 2021

Forecast Year: 2022-2027

Key Vendors

  • Agilent Technologies
    • Business Overview
    • Product Offerings
    • Key Strategies
    • Key Strengths
    • Key Opportunities
  • Bio-Rad Laboratories
  • Danaher
  • Thermo Fisher Scientific
  • PerkinElmer
  • BGI Genomics

Other Prominent Vendors by Product

  • Bruker
    • Business Overview
    • Product Offerings
  • DiaSorin
  • HORIBA
  • Illumina
  • INOVIQ
  • LI-COR
  • Nautilus Biotechnology
  • Proteome Factory
  • QIAGEN
  • Rhythm Biosciences
  • Shimadzu Scientific Instruments
  • Seer
  • Waters

Other Prominent Vendors by Service

  • Applied Biomics
    • Business Overview
    • Product Offerings
  • Creative Proteomics
  • Poochon Scientific
  • SomaLogic
  • Vproteomics

Other Prominent Vendors by Product & Services

  • Abcam
    • Business Overview
    • Product Offerings
  • AnteoTech
  • AYOXXA Biosystems
  • Biognosys
  • Geneilabs
  • Grace Bio-Labs
  • ITSI-Biosciences
  • MSAID
  • Olink
  • Promega
  • Proteomics International
  • Quanterix

Market Segmentation by Product

  • Consumables & Reagents
  • Instruments & Software
  • Services

Market Segmentation by Application

  • DDD & TR
  • Clinical
  • Applications
  • Forensic & Applied Proteomics

Market Segmentation by End-User

  • Pharma & Biotech
  • Academic & Research Institutes
  • Hospitals
  • Diagnostic & Forensic

Regions

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
  • APAC
    • Japan
    • China
    • South Korea
    • Australia
    • India
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Turkey
    • South Africa
    • Saudi Arabia

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

4.1 MARKET DEFINITION

4.1.1 INCLUSIONS

4.1.2 MARKET ESTIMATION CAVEATS

4.2 BASE YEAR

4.3 SCOPE OF THE STUDY

4.3.1 MARKET SEGMENTATION BY PRODUCT

4.3.2 MARKET SEGMENTATION BY APPLICATION

4.3.3 MARKET SEGMENTATION BY END USER

4.3.4 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

5.1 KEY CAVEATS

5.2 CURRENCY CONVERSION

5.3 MARKET DERIVATION

6 MARKET AT A GLANCE

7 INTRODUCTION

7.1 OVERVIEW

7.1.1 LOW-THROUGHPUT METHODS

7.1.2 HIGH-THROUGHPUT METHODS

8 MARKET OPPORTUNITIES & TRENDS

8.1 INCREASING PROMINENCE OF NANOPROTEOMICS

8.2 DEVELOPMENTS IN MASS SPECTROMETRY-BASED PROTEOMICS

8.3 PROMINENT ROLE OF PROTEOMICS IN DIABETES MANAGEMENT

9 MARKET GROWTH ENABLERS

9.1 RISING NUMBER OF R&D PROJECTS IN PROTEOMICS

9.2 INCREASING PREVALENCE OF CANCER AND VARIOUS GENETIC DISORDERS

9.3 GROWING FOCUS ON DEVELOPMENT OF PRECISION MEDICINE

10 MARKET RESTRAINTS

10.1 LIMITATIONS ASSOCIATED WITH ACCESSING PROTEOME

10.2 DEARTH OF SKILLED PROFESSIONALS

10.3 STRICT REGULATORY NORMS & HIGH COST OF INSTRUMENTS

11 MARKET LANDSCAPE

11.1 MARKET OVERVIEW

11.2 MARKET SIZE & FORECAST

11.2.1 INSIGHTS BY PRODUCT

11.2.2 INSIGHTS BY APPLICATION

11.2.3 INSIGHTS BY END USERS

11.2.4 INSIGHTS BY GEOGRAPHY

11.3 FIVE FORCES ANALYSIS

11.3.1 THREAT OF NEW ENTRANTS

11.3.2 BARGAINING POWER OF SUPPLIERS

11.3.3 BARGAINING POWER OF BUYERS

11.3.4 THREAT OF SUBSTITUTES

11.3.5 COMPETITIVE RIVALRY

12 PRODUCT

12.1 MARKET SNAPSHOT & GROWTH ENGINE

12.2 MARKET OVERVIEW

12.3 CONSUMABLES & REAGENTS

12.3.1 MARKET OVERVIEW

12.3.2 MARKET SIZE & FORECAST

12.3.3 MARKET BY GEOGRAPHY

12.4 INSTRUMENTS & SOFTWARE

12.4.1 MARKET OVERVIEW

12.4.2 MARKET SIZE & FORECAST

12.4.3 MARKET BY GEOGRAPHY

12.5 SERVICES

12.5.1 MARKET OVERVIEW

12.5.2 MARKET SIZE & FORECAST

12.5.3 MARKET BY GEOGRAPHY

13 APPLICATION

13.1 MARKET SNAPSHOT & GROWTH ENGINE

13.2 MARKET OVERVIEW

13.3 DRUG DISCOVERY & DEVELOPMENT AND TRANSLATIONAL RESEARCH

13.3.1 MARKET OVERVIEW

13.3.2 MARKET SIZE & FORECAST

13.3.3 MARKET BY GEOGRAPHY

13.4 CLINICAL APPLICATIONS

13.4.1 MARKET OVERVIEW

13.4.2 MARKET SIZE & FORECAST

13.4.3 MARKET BY GEOGRAPHY

13.5 FORENSICS & APPLIED PROTEOMICS

13.5.1 MARKET OVERVIEW

13.5.2 MARKET SIZE & FORECAST

13.5.3 MARKET BY GEOGRAPHY

14 END USER

14.1 MARKET SNAPSHOT & GROWTH ENGINE

14.2 MARKET OVERVIEW

14.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

14.3.1 MARKET OVERVIEW

14.3.2 MARKET SIZE & FORECAST

14.3.3 MARKET BY GEOGRAPHY

14.4 ACADEMIC & RESEARCH INSTITUTES

14.4.1 MARKET OVERVIEW

14.4.2 MARKET SIZE & FORECAST

14.4.3 MARKET BY GEOGRAPHY

14.5 HOSPITALS

14.5.1 MARKET OVERVIEW

14.5.2 MARKET SIZE & FORECAST

14.5.3 MARKET BY GEOGRAPHY

14.6 DIAGNOSTIC & FORENSIC LABORATORIES

14.6.1 MARKET OVERVIEW

14.6.2 MARKET SIZE & FORECAST

14.6.3 MARKET BY GEOGRAPHY

15 GEOGRAPHY

15.1 MARKET SNAPSHOT & GROWTH ENGINE

15.2 GEOGRAPHIC OVERVIEW

16 NORTH AMERICA

16.1 MARKET OVERVIEW

16.2 MARKET SIZE & FORECAST

16.3 NORTH AMERICA: PRODUCT SEGMENTATION

16.4 NORTH AMERICA: APPLICATION SEGMENTATION

16.5 NORTH AMERICA: END-USER SEGMENTATION

16.6 KEY COUNTRIES

16.6.1 US: MARKET SIZE & FORECAST

16.6.2 CANADA: MARKET SIZE & FORECAST

17 EUROPE

17.1 MARKET OVERVIEW

17.2 MARKET SIZE & FORECAST

17.3 EUROPE: PRODUCT SEGMENTATION

17.4 EUROPE: APPLICATION SEGMENTATION

17.5 EUROPE: END-USER SEGMENTATION

17.6 KEY COUNTRIES

17.6.1 GERMANY: MARKET SIZE & FORECAST

17.6.2 FRANCE: MARKET SIZE & FORECAST

17.6.3 UK: MARKET SIZE & FORECAST

17.6.4 ITALY: MARKET SIZE & FORECAST

17.6.5 SPAIN: MARKET SIZE & FORECAST

18 APAC

18.1 MARKET OVERVIEW

18.2 MARKET SIZE & FORECAST

18.3 APAC: PRODUCT SEGMENTATION

18.4 APAC: APPLICATION SEGMENTATION

18.5 APAC: END-USER SEGMENTATION

18.6 KEY COUNTRIES

18.6.1 JAPAN: MARKET SIZE & FORECAST

18.6.2 CHINA: MARKET SIZE & FORECAST

18.6.3 SOUTH KOREA: MARKET SIZE & FORECAST

18.6.4 AUSTRALIA: MARKET SIZE & FORECAST

18.6.5 INDIA: MARKET SIZE & FORECAST

19 LATIN AMERICA

19.1 MARKET OVERVIEW

19.2 MARKET SIZE & FORECAST

19.3 LATIN AMERICA: PRODUCT SEGMENTATION

19.4 LATIN AMERICA: APPLICATION SEGMENTATION

19.5 LATIN AMERICA: END-USER SEGMENTATION

19.6 KEY COUNTRIES

19.6.1 BRAZIL: MARKET SIZE & FORECAST

19.6.2 MEXICO: MARKET SIZE & FORECAST

19.6.3 ARGENTINA: MARKET SIZE & FORECAST

20 MIDDLE EAST & AFRICA

20.1 MARKET OVERVIEW

20.2 MARKET SIZE & FORECAST

20.3 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION

20.4 MIDDLE EAST & AFRICA: APPLICATION SEGMENTATION

20.5 MIDDLE EAST & AFRICA: END-USER SEGMENTATION

20.6 KEY COUNTRIES

20.6.1 TURKEY: MARKET SIZE & FORECAST

20.6.2 SOUTH AFRICA: MARKET SIZE & FORECAST

20.6.3 SAUDI ARABIA: MARKET SIZE & FORECAST

21 COMPETITIVE LANDSCAPE

21.1 COMPETITION OVERVIEW

21.2 MARKET SHARE ANALYSIS

21.2.1 AGILENT TECHNOLOGIES

21.2.2 BIO-RAD LABORATORIES

21.2.3 THERMO FISHER SCIENTIFIC

21.2.4 DANAHER

21.2.5 PERKINELMER

21.2.6 BGI GROUP

22 KEY COMPANY PROFILES

22.1 AGILENT TECHNOLOGIES

22.1.1 BUSINESS OVERVIEW

22.1.2 PRODUCT OFFERINGS

22.1.3 KEY STRATEGIES

22.1.4 KEY STRENGTHS

22.1.5 KEY OPPORTUNITIES

22.2 BIO-RAD LABORATORIES

22.2.1 BUSINESS OVERVIEW

22.2.2 PRODUCT OFFERINGS

22.2.3 KEY STRATEGIES

22.2.4 KEY STRENGTHS

22.2.5 KEY OPPORTUNITIES

22.3 DANAHER

22.3.1 BUSINESS OVERVIEW

22.3.2 PRODUCT OFFERINGS

22.3.3 KEY STRATEGIES

22.3.4 KEY STRENGTHS

22.3.5 KEY OPPORTUNITIES

22.4 THERMO FISHER SCIENTIFIC

22.4.1 BUSINESS OVERVIEW

22.4.2 PRODUCT OFFERINGS

22.4.3 KEY STRATEGIES

22.4.4 KEY STRENGTHS

22.4.5 KEY OPPORTUNITIES

22.5 PERKINELMER

22.5.1 BUSINESS OVERVIEW

22.5.2 PRODUCT OFFERINGS

22.5.3 KEY STRATEGIES

22.5.4 KEY STRENGTHS

22.5.5 KEY OPPORTUNITIES

22.6 BGI GROUP

22.6.1 BUSINESS OVERVIEW

22.6.2 PRODUCT OFFERINGS

22.6.3 KEY STRATEGIES

22.6.4 KEY STRENGTHS

22.6.5 KEY OPPORTUNITIES

23 OTHER PROMINENT VENDORS – BY PRODUCT

23.1 BRUKER

23.1.1 BUSINESS OVERVIEW

23.1.2 PRODUCT OFFERINGS

23.2 DIASORIN

23.2.1 BUSINESS OVERVIEW

23.2.2 PRODUCT OFFERINGS

23.3 HORIBA

23.3.1 BUSINESS OVERVIEW

23.3.2 PRODUCT OFFERINGS

23.4 ILLUMINA

23.4.1 BUSINESS OVERVIEW

23.4.2 PRODUCT OFFERINGS

23.5 INOVIQ

23.5.1 BUSINESS OVERVIEW

23.5.2 PRODUCT OFFERINGS

23.6 LI-COR BIOSCIENCES

23.6.1 BUSINESS OVERVIEW

23.6.2 PRODUCT OFFERINGS

23.7 NAUTILUS BIOTECHNOLOGY

23.7.1 BUSINESS OVERVIEW

23.7.2 PRODUCT OFFERINGS

23.8 PROTEOME FACTORY

23.8.1 BUSINESS OVERVIEW

23.8.2 PRODUCT OFFERINGS

23.9 QIAGEN

23.9.1 BUSINESS OVERVIEW

23.9.2 PRODUCT OFFERINGS

23.10 RHYTHM BIOSCIENCES

23.10.1 BUSINESS OVERVIEW

23.10.2 PRODUCT OFFERINGS

23.11 SHIMADZU SCIENTIFIC INSTRUMENTS

23.11.1 BUSINESS OVERVIEW

23.11.2 PRODUCT OFFERINGS

23.12 SEER

23.12.1 BUSINESS OVERVIEW

23.12.2 PRODUCT OFFERINGS

23.13 WATERS

23.13.1 BUSINESS OVERVIEW

23.13.2 PRODUCT OFFERINGS

24 SERVICE PROVIDERS

24.1 APPLIED BIOMICS

24.1.1 BUSINESS OVERVIEW

24.1.2 PRODUCT OFFERINGS

24.2 CREATIVE PROTEOMICS

24.2.1 BUSINESS OVERVIEW

24.2.2 PRODUCT OFFERINGS

24.3 POOCHON SCIENTIFIC

24.3.1 BUSINESS OVERVIEW

24.3.2 PRODUCT OFFERINGS

24.4 SOMALOGIC

24.4.1 BUSINESS OVERVIEW

24.4.2 PRODUCT OFFERINGS

24.5 VPROTEOMICS

24.5.1 BUSINESS OVERVIEW

24.5.2 PRODUCT OFFERINGS

25 PRODUCT & SERVICE PROVIDERS

25.1 ABCAM

25.1.1 BUSINESS OVERVIEW

25.1.2 PRODUCT & SERVICE OFFERINGS

25.2 ANTEOTECH

25.2.1 BUSINESS OVERVIEW

25.2.2 PRODUCT & SERVICE OFFERINGS

25.3 AYOXXA BIOSYSTEMS

25.3.1 BUSINESS OVERVIEW

25.3.2 PRODUCT & SERVICE OFFERINGS

25.4 BIOGNOSYS

25.4.1 BUSINESS OVERVIEW

25.4.2 PRODUCT & SERVICE OFFERINGS

25.5 GENEI LABORATORIES

25.5.1 BUSINESS OVERVIEW

25.5.2 PRODUCT OFFERINGS

25.6 GRACE BIO-LABS

25.6.1 BUSINESS OVERVIEW

25.6.2 PRODUCT & SERVICE OFFERINGS

25.7 ITSI-BIOSCIENCES

25.7.1 BUSINESS OVERVIEW

25.7.2 PRODUCT & SERVICE OFFERINGS

25.8 MSAID

25.8.1 BUSINESS OVERVIEW

25.8.2 PRODUCT & SERVICE OFFERINGS

25.9 OLINK

25.9.1 BUSINESS OVERVIEW

25.9.2 PRODUCT & SERVICE OFFERINGS

25.10 PROMEGA

25.10.1 BUSINESS OVERVIEW

25.10.2 PRODUCT & SERVICE OFFERINGS

25.11 PROTEOMICS INTERNATIONAL

25.11.1 BUSINESS OVERVIEW

25.11.2 PRODUCT & SERVICE OFFERINGS

25.12 QUANTERIX

25.12.1 BUSINESS OVERVIEW

25.12.2 PRODUCT & SERVICE OFFERINGS

26 REPORT SUMMARY

26.1 KEY TAKEAWAYS

26.2 STRATEGIC RECOMMENDATIONS

27 QUANTITATIVE SUMMARY

27.1 MARKET BY GEOGRAPHY

27.2 MARKET BY PRODUCT

27.3 MARKET BY APPLICATION

27.4 MARKET BY END USER

27.5 NORTH AMERICA BY PRODUCT

27.6 NORTH AMERICA BY APPLICATION

27.7 NORTH AMERICA BY END USER

27.8 EUROPE BY PRODUCT

27.9 EUROPE BY APPLICATION

27.10 EUROPE BY END USER

27.11 APAC BY PRODUCT

27.12 APAC BY APPLICATION

27.13 APAC BY END USER

27.14 LATIN AMERICA BY PRODUCT

27.15 LATIN AMERICA BY APPLICATION

27.16 LATIN AMERICA BY END USER

27.17 MIDDLE EAST & AFRICA BY PRODUCT

27.18 MIDDLE EAST & AFRICA BY APPLICATION

27.19 MIDDLE EAST & AFRICA BY END USER

28 APPENDIX

28.1 ABBREVIATIONS

LIST OF EXHIBITS

EXHIBIT 1 SEGMENTATION OF GLOBAL PROTEOMICS MARKET

EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021

EXHIBIT 3 APPLICATION AREAS OF PROTEOMICS

EXHIBIT 4 FOCUS AREAS OF TYPICAL PROTEOMIC STUDIES

EXHIBIT 5 PROTEOMICS COMPANIES GENERATING HIGH REVENUES ($ MILLION)

EXHIBIT 6 IMPACT OF INCREASING PROMINENCE OF NANOPROTEOMICS

EXHIBIT 7 ADVANTAGES OF NANO PROTEOMICS

EXHIBIT 8 IMPACT OF DEVELOPMENTS IN MASS SPECTROMETRY-BASED PROTEOMICS

EXHIBIT 9 IMPACT OF PROMINENT ROLE OF PROTEOMICS IN DIABETES MANAGEMENT

EXHIBIT 10 PREVALENCE OF DIABETES AMONG ADULTS WORLDWIDE (20–79 AGE GROUP)

EXHIBIT 11 IMPACT OF RISING NUMBER OF R&D PROJECTS IN PROTEOMICS

EXHIBIT 12 IMPACT OF INCREASING PREVALENCE OF CANCER AND VARIOUS GENETIC DISORDERS

EXHIBIT 13 NUMBER OF NEW CASES OF TYPES OF CANCER IN 2020 (MILLION)

EXHIBIT 14 IMPACT OF GROWING FOCUS ON DEVELOPMENT OF PRECISION MEDICINE

EXHIBIT 15 IMPACT OF LIMITATIONS ASSOCIATED WITH ACCESSING PROTEOME

EXHIBIT 16 IMPACT OF DEARTH OF SKILLED PROFESSIONALS

EXHIBIT 17 KEY CHALLENGES IN SELECTING METHODS FOR PROTEOMICS RESEARCH

EXHIBIT 18 IMPACT OF STRICT REGULATORY NORMS & HIGH COST OF INSTRUMENTS

EXHIBIT 19 GLOBAL PROTEOMICS MARKET 2021–2027 ($ BILLION)

EXHIBIT 20 GLOBAL PROTEOMICS MARKET BY PRODUCT 2021 & 2027 (%)

EXHIBIT 21 GLOBAL PROTEOMICS MARKET BY APPLICATION 2021 & 2027 (%)

EXHIBIT 22 GLOBAL PROTEOMICS MARKET BY END USER 2021 & 2027 (%)

EXHIBIT 23 GLOBAL PROTEOMICS MARKET BY GEOGRAPHY

EXHIBIT 24 FIVE FORCES ANALYSIS 2021

EXHIBIT 25 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 26 GLOBAL PROTEOMICS MARKET BY PRODUCT

EXHIBIT 27 GLOBAL PROTEOMICS MARKET BY PRODUCT

EXHIBIT 28 GLOBAL PROTEOMICS MARKET BY PRODUCT: GROWTH ANALYSIS

EXHIBIT 29 GLOBAL PROTEOMICS MARKET BY PRODUCT: INCREMENTAL GROWTH ($ BILLION)

EXHIBIT 30 GLOBAL PROTEOMICS MARKET BY PRODUCT: ABSOLUTE GROWTH (%)

EXHIBIT 31 REAGENTS OFFERED BY COMPANIES AND THEIR APPLICATIONS

EXHIBIT 32 LIST OF CONSUMABLES OFFERED BY BIO-RAD LABORATORIES

EXHIBIT 33 GLOBAL PROTEOMICS MARKET BY CONSUMABLES & REAGENTS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 34 GLOBAL PROTEOMICS MARKET BY CONSUMABLES & REAGENTS 2021–2027 ($ BILLION)

EXHIBIT 35 REAGENTS INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 36 GLOBAL PROTEOMICS MARKET BY INSTRUMENTS & SOFTWARE: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 37 GLOBAL PROTEOMICS MARKET BY INSTRUMENTS & SOFTWARE 2021–2027 ($ BILLION)

EXHIBIT 38 INSTRUMENTS INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 39 GLOBAL PROTEOMICS MARKET BY SERVICES 2021–2027 ($ BILLION)

EXHIBIT 40 GLOBAL PROTEOMICS MARKET BY SERVICES: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 41 SERVICES INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 42 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027

EXHIBIT 43 GLOBAL PROTEOMICS MARKET BY APPLICATION

EXHIBIT 44 GLOBAL PROTEOMICS MARKET BY APPLICATION

EXHIBIT 45 GROWTH ANALYSIS: PROTEOMICS MARKET BY APPLICATION

EXHIBIT 46 GLOBAL PROTEOMICS MARKET BY APPLICATION: INCREMENTAL GROWTH ($ BILLION)

EXHIBIT 47 GLOBAL PROTEOMICS MARKET BY APPLICATION – ABSOLUTE GROWTH (%)

EXHIBIT 48 GLOBAL PROTEOMICS MARKET BY DRUG DISCOVERY & DEVELOPMENT AND TRANSLATIONAL RESEARCH 2021–2027 ($ BILLION)

EXHIBIT 49 GLOBAL PROTEOMICS MARKET BY DDD & TR: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 50 DDD & TR INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 51 GLOBAL PROTEOMICS MARKET BY CLINICAL APPLICATIONS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 52 GLOBAL PROTEOMICS MARKET BY CLINICAL APPLICATIONS 2021–2027 ($ BILLION)

EXHIBIT 53 CLINICAL APPLICATIONS INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 54 GLOBAL PROTEOMICS MARKET BY FORENSICS & APPLIED PROTEOMICS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 55 GLOBAL PROTEOMICS MARKET BY FORENSICS & APPLIED PROTEOMICS 2021–2027 ($ BILLION)

EXHIBIT 56 FORENSICS & APPLIED PROTEOMICS INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 57 INCREMENTAL GROWTH BY END USER 2021 & 2027

EXHIBIT 58 GLOBAL PROTEOMICS MARKET BY END USER

EXHIBIT 59 GLOBAL PROTEOMICS MARKET BY END USER

EXHIBIT 60 GROWTH ANALYSIS: PROTEOMICS MARKET BY END USER

EXHIBIT 61 GLOBAL PROTEOMICS MARKET BY END USER: INCREMENTAL GROWTH ($ BILLION)

EXHIBIT 62 GLOBAL PROTEOMICS MARKET BY END USER: ABSOLUTE GROWTH (%)

EXHIBIT 63 APPLICATIONS OF PROTEOMICS IN VARIOUS SECTIONS OF PHARMACEUTICAL COMPANIES

EXHIBIT 64 CURRENT AND FUTURE STATE OF PROTEOMICS IN PHARMACEUTICAL INDUSTRY

EXHIBIT 65 GLOBAL PROTEOMICS MARKET BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 66 GLOBAL PROTEOMICS MARKET BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 2021–2027 ($ BILLION)

EXHIBIT 67 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 68 GLOBAL PROTEOMICS MARKET BY ACADEMIC & RESEARCH INSTITUTES 2021–2027 ($ BILLION)

EXHIBIT 69 GLOBAL PROTEOMICS MARKET BY ACADEMIC & RESEARCH INSTITUTES: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 70 ACADEMIC & RESEARCH INSTITUTES INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 71 GLOBAL PROTEOMICS MARKET BY HOSPITALS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 72 GLOBAL PROTEOMICS MARKET BY HOSPITALS 2021–2027 ($ BILLION)

EXHIBIT 73 HOSPITALS INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 74 GLOBAL PROTEOMICS MARKET BY DIAGNOSTIC & FORENSIC LABORATORIES: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 75 GLOBAL PROTEOMICS MARKET BY DIAGNOSTIC & FORENSIC LABORATORIES 2021–2027 ($ BILLION)

EXHIBIT 76 DIAGNOSTIC & FORENSIC LABORATORIES INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 77 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 78 GLOBAL PROTEOMICS MARKET BY GEOGRAPHY

EXHIBIT 79 GLOBAL PROTEOMICS MARKET BY GEOGRAPHY: INCREMENTAL GROWTH ($ BILLION)

EXHIBIT 80 GLOBAL PROTEOMICS MARKET BY GEOGRAPHY: ABSOLUTE GROWTH (%)

EXHIBIT 81 NORTH AMERICA PROTEOMICS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 82 NORTH AMERICA PROTEOMICS MARKET: KEY COUNTRIES 2021 ($ BILLION)

EXHIBIT 83 NORTH AMERICA PROTEOMICS MARKET 2021–2027 ($ BILLION)

EXHIBIT 84 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 85 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027

EXHIBIT 86 INCREMENTAL GROWTH BY END USER 2021 & 2027

EXHIBIT 87 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027

EXHIBIT 88 PERSONALIZED MEDICINES WITH SPECIFIC BIOMARKERS: TOP 20% OF FDA APPROVALS BETWEEN 2005 & 2019

EXHIBIT 89 US PROTEOMICS MARKET 2021–2027 ($ BILLION)

EXHIBIT 90 CIHR PROJECTED LEVERAGE BY PARTNER TYPE FOR PERSONALIZED MEDICINE BUSINESS

EXHIBIT 91 CANADA PROTEOMICS MARKET 2021–2027 ($ BILLION)

EXHIBIT 92 EUROPE PROTEOMICS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 93 EUROPE PROTEOMICS MARKET: KEY COUNTRIES 2021 ($ BILLION)

EXHIBIT 94 EUROPE PROTEOMICS MARKET 2021–2027 ($ BILLION)

EXHIBIT 95 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 96 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027

EXHIBIT 97 INCREMENTAL GROWTH BY END USER 2021 & 2027

EXHIBIT 98 INCREMENTAL GROWTH IN EUROPE 2021 & 2027

EXHIBIT 99 GERMANY PROTEOMICS MARKET 2021–2027 ($ BILLION)

EXHIBIT 100 DISTRIBUTION OF SELECTED PROJECTS ACCORDING TO EQUIPMENT CATEGORIES 2016–2019

EXHIBIT 101 PROTEOMICS MARKET IN FRANCE 2021–2027 ($ BILLION)

EXHIBIT 102 UK PROTEOMICS MARKET 2021–2027 ($ BILLION)

EXHIBIT 103 ITALY PROTEOMICS MARKET 2021–2027 ($ BILLION)

EXHIBIT 104 SPAIN PROTEOMICS MARKET 2021–2027 ($ BILLION)

EXHIBIT 105 APAC PROTEOMICS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 106 APAC PROTEOMICS MARKET: KEY COUNTRIES 2021 ($ BILLION)

EXHIBIT 107 APAC PROTEOMICS MARKET 2021–2027 ($ BILLION)

EXHIBIT 108 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 109 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027

EXHIBIT 110 INCREMENTAL GROWTH BY END USER 2021 & 2027

EXHIBIT 111 INCREMENTAL GROWTH IN APAC 2021 & 2027

EXHIBIT 112 JAPAN PROTEOMICS MARKET 2021–2027 ($ BILLION)

EXHIBIT 113 CHINA PROTEOMICS MARKET 2021–2027 ($ BILLION)

EXHIBIT 114 SOUTH KOREA PROTEOMICS MARKET 2021–2027 ($ BILLION)

EXHIBIT 115 AUSTRALIA PROTEOMICS MARKET 2021–2027 ($ BILLION)

EXHIBIT 116 PROTEOMICS MARKET IN INDIA 2021–2027 ($ BILLION)

EXHIBIT 117 LATIN AMERICA PROTEOMICS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 118 LATIN AMERICA PROTEOMICS MARKET: KEY COUNTRIES 2021 ($ BILLION)

EXHIBIT 119 LATIN AMERICA PROTEOMICS MARKET 2021–2027 ($ BILLION)

EXHIBIT 120 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 121 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027

EXHIBIT 122 INCREMENTAL GROWTH BY END USER 2021 & 2027

EXHIBIT 123 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027

EXHIBIT 124 BRAZIL PROTEOMICS MARKET 2021–2027 ($ BILLION)

EXHIBIT 125 MEXICO PROTEOMICS MARKET 2021–2027 ($ BILLION)

EXHIBIT 126 ARGENTINA PROTEOMICS MARKET 2021–2027 ($ BILLION)

EXHIBIT 127 MIDDLE EAST & AFRICA PROTEOMICS MARKET 2021–2027 ($ BILLION)

EXHIBIT 128 MIDDLE EAST & AFRICA PROTEOMICS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 129 MIDDLE EAST & AFRICA PROTEOMICS MARKET: KEY COUNTRIES 2021 ($ BILLION)

EXHIBIT 130 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 131 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027

EXHIBIT 132 INCREMENTAL GROWTH BY END USER 2021 & 2027

EXHIBIT 133 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027

EXHIBIT 134 TURKEY PROTEOMICS MARKET 2021–2027 ($ BILLION)

EXHIBIT 135 SOUTH AFRICA PROTEOMICS MARKET 2021–2027 ($ BILLION)

EXHIBIT 136 SAUDI ARABIA PROTEOMICS MARKET 2021–2027 ($ BILLION)

EXHIBIT 137 PURE & DIVERSIFIED COMPANIES IN GLOBAL PROTEOMICS MARKET

EXHIBIT 138 GLOBAL PROTEOMICS MARKET: MARKET DOMINANCE ANALYSIS

EXHIBIT 139 GLOBAL PROTEOMICS MARKET: KEY VENDORS CAPABILITIES & EXPERTISE ASSESSMENT

EXHIBIT 140 AGILENT TECHNOLOGIES: TOTAL REVENUE 2019–2021($ MILLION)

EXHIBIT 141 AGILENT TECHNOLOGIES: SALES BREAKDOWN BY GEOGRAPHY ($ MILLION)

EXHIBIT 142 BIO-RAD LABORATORIES: TOTAL REVENUE 2019–2021($ MILLION)

EXHIBIT 143 BIO-RAD LABORATORIES: R&D EXPENDITURE 2019–2021 ($ MILLION)

EXHIBIT 144 BIO-RAD LABORATORIES: SALES BREAKDOWN BY GEOGRAPHY ($ MILLION)

EXHIBIT 145 THERMO FISHER SCIENTIFIC: TOTAL REVENUE 2019–2021($ MILLION)

EXHIBIT 146 THERMO FISHER SCIENTIFIC: R&D EXPENDITURE 2019–2021 ($ MILLION)

EXHIBIT 147 THERMO FISHER SCIENTIFIC: SALES BREAKDOWN BY GEOGRAPHY ($ MILLION)

EXHIBIT 148 PERKINELMER: TOTAL REVENUE 2019–2021($ MILLION)

EXHIBIT 149 PERKINELMER: R&D EXPENDITURE 2019–2021($ MILLION)

LIST OF TABLES

TABLE 1 KEY CAVEATS

TABLE 2 CURRENCY CONVERSION 2015−2021

TABLE 3 GLOBAL DIABETES MARKET SIZE ($ MILLION)

TABLE 4 OVERVIEW OF PROTEOMIC TECHNIQUES USED TO REVEAL NOVEL BIOLOGY OF VARIOUS INFECTIOUS DISEASES

TABLE 5 LIST OF CANCER BIOMARKERS IDENTIFIED USING PROTEOMICS APPROACHES

TABLE 6 APPLICATIONS OF FORENSIC PROTEOMICS USING HUMAN SAMPLES

TABLE 7 AGILENT TECHNOLOGIES: MAJOR PRODUCT OFFERINGS

TABLE 8 BIO-RAD LABORATORIES: MAJOR PRODUCT OFFERINGS

TABLE 9 DANAHER: MAJOR PRODUCT OFFERINGS

TABLE 10 THERMO FISHER SCIENTIFIC: MAJOR PRODUCT OFFERINGS

TABLE 11 PERKINELMER: MAJOR PRODUCT OFFERINGS

TABLE 12 BGI GROUP: MAJOR PRODUCT OFFERINGS

TABLE 13 BRUKER: MAJOR PRODUCT OFFERINGS

TABLE 14 DIASORIN: MAJOR PRODUCT OFFERINGS

TABLE 15 HORIBA: MAJOR PRODUCT OFFERINGS

TABLE 16 ILLUMINA: MAJOR PRODUCT OFFERINGS

TABLE 17 INOVIQ: MAJOR PRODUCT OFFERINGS

TABLE 18 LI-COR BIOSCIENCES: MAJOR PRODUCT OFFERINGS

TABLE 19 NAUTILUS BIOTECHNOLOGY: MAJOR PRODUCT OFFERINGS

TABLE 20 PROTEOME FACTORY: MAJOR PRODUCT OFFERINGS

TABLE 21 QIAGEN: MAJOR PRODUCT OFFERINGS

TABLE 22 RHYTHM BIOSCIENCES: MAJOR PRODUCT OFFERINGS

TABLE 23 SHIMADZU SCIENTIFIC INSTRUMENTS: MAJOR PRODUCT OFFERINGS

TABLE 24 SEER: MAJOR PRODUCT OFFERINGS

TABLE 25 WATERS: MAJOR PRODUCT OFFERINGS

TABLE 26 APPLIED BIOMICS: MAJOR SERVICE OFFERINGS

TABLE 27 CREATIVE PROTEOMICS: MAJOR SERVICE OFFERINGS

TABLE 28 POOCHON SCIENTIFIC: MAJOR SERVICE OFFERINGS

TABLE 29 SOMALOGIC: MAJOR SERVICE OFFERINGS

TABLE 30 VPROTEOMICS: MAJOR SERVICE OFFERINGS

TABLE 31 ABCAM: MAJOR PRODUCT OFFERINGS

TABLE 32 ANTEOTECH:  MAJOR PRODUCT OFFERINGS

TABLE 33 AYOXXA BIOSCIENCES: MAJOR PRODUCT OFFERINGS

TABLE 34 BIOGNOSYS: MAJOR PRODUCT OFFERINGS

TABLE 35 GENEI LABORATORIES: MAJOR PRODUCT OFFERINGS

TABLE 36 GRACE BIO-LABS: MAJOR PRODUCT OFFERINGS

TABLE 37 ITSI-BIOSCIENCES: MAJOR PRODUCT OFFERINGS

TABLE 38 MSAID: MAJOR PRODUCT OFFERINGS

TABLE 39 OLINK: MAJOR PRODUCT OFFERINGS

TABLE 40 PROMEGA: MAJOR PRODUCT OFFERINGS

TABLE 41 PROTEOMICS INTERNATIONAL: MAJOR PRODUCT OFFERINGS

TABLE 42 QUANTERIX: MAJOR PRODUCT OFFERINGS

TABLE 43 GLOBAL PROTEOMICS MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)

TABLE 44 GLOBAL PROTEOMICS MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 45 GLOBAL PROTEOMICS MARKET BY PRODUCT 2021–2027 ($ BILLION)

TABLE 46 GLOBAL PROTEOMICS MARKET BY PRODUCT 2021–2027 (%)

TABLE 47 GLOBAL PROTEOMICS MARKET BY APPLICATION 2021–2027 ($ BILLION)

TABLE 48 GLOBAL PROTEOMICS MARKET BY APPLICATION 2021–2027 (%)

TABLE 49 GLOBAL PROTEOMICS MARKET BY END USER 2021–2027 ($ BILLION)

TABLE 50 GLOBAL PROTEOMICS MARKET BY END USER 2021–2027 (%)

TABLE 51 NORTH AMERICA PROTEOMICS MARKET BY PRODUCT 2021–2027 ($ BILLION)

TABLE 52 NORTH AMERICA PROTEOMICS MARKET BY PRODUCT 2021–2027 (%)

TABLE 53 NORTH AMERICA PROTEOMICS MARKET BY APPLICATION 2021–2027 ($ BILLION)

TABLE 54 NORTH AMERICA PROTEOMICS MARKET BY APPLICATION 2021–2027 (%)

TABLE 55 NORTH AMERICA PROTEOMICS MARKET BY END USER 2021–2027 ($ BILLION)

TABLE 56 NORTH AMERICA PROTEOMICS MARKET BY END USER 2021–2027 (%)

TABLE 57 EUROPE PROTEOMICS MARKET BY PRODUCT 2021–2027 ($ BILLION)

TABLE 58 EUROPE PROTEOMICS MARKET BY PRODUCT 2021–2027 (%)

TABLE 59 EUROPE PROTEOMICS MARKET BY APPLICATION 2021–2027 ($ BILLION)

TABLE 60 EUROPE PROTEOMICS MARKET BY APPLICATION 2021–2027 (%)

TABLE 61 EUROPE PROTEOMICS MARKET BY END USER 2021–2027 ($ BILLION)

TABLE 62 EUROPE PROTEOMICS MARKET BY END USER 2021–2027 (%)

TABLE 63 APAC PROTEOMICS MARKET BY PRODUCT 2021–2027 ($ BILLION)

TABLE 64 APAC PROTEOMICS MARKET BY PRODUCT 2021–2027 (%)

TABLE 65 APAC PROTEOMICS MARKET BY APPLICATION 2021–2027 ($ BILLION)

TABLE 66 APAC PROTEOMICS MARKET BY APPLICATION 2021–2027 (%)

TABLE 67 APAC PROTEOMICS MARKET BY END USER 2021–2027 ($ BILLION)

TABLE 68 APAC PROTEOMICS MARKET BY END USER 2021–2027 (%)

TABLE 69 LATIN AMERICA PROTEOMICS MARKET BY PRODUCT 2021–2027 ($ BILLION)

TABLE 70 LATIN AMERICA PROTEOMICS MARKET BY PRODUCT 2021–2027 (%)

TABLE 71 LATIN AMERICA PROTEOMICS MARKET BY APPLICATION 2021–2027 ($ BILLION)

TABLE 72 LATIN AMERICA PROTEOMICS MARKET BY APPLICATION 2021–2027 (%)

TABLE 73 LATIN AMERICA PROTEOMICS MARKET BY END USER 2021–2027 ($ BILLION)

TABLE 74 LATIN AMERICA PROTEOMICS MARKET BY END USER 2021–2027 (%)

TABLE 75 MIDDLE EAST & AFRICA PROTEOMICS MARKET BY PRODUCT 2021–2027 ($ BILLION)

TABLE 76 MIDDLE EAST & AFRICA PROTEOMICS MARKET BY PRODUCT 2021–2027 (%)

TABLE 77 MIDDLE EAST & AFRICA PROTEOMICS MARKET BY APPLICATION 2021–2027 ($ BILLION)

TABLE 78 MIDDLE EAST & AFRICA PROTEOMICS MARKET BY APPLICATION 2021–2027 (%)

TABLE 79 MIDDLE EAST & AFRICA PROTEOMICS MARKET BY END USER 2021–2027 ($ BILLION)

TABLE 80 MIDDLE EAST & AFRICA PROTEOMICS MARKET BY END USER 2021–2027 (%)

Select a license type that suits your business needs

single-user Single User Licence
$3500.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$3995.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$4995.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Interested in data center portfolio for this report?
Click here

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date